Ads
related to: new rectal cancer treatment breakthrough- Dosing Information
See Recommended Dosage
For This Approved Treatment
- Financial Support
If Eligible, Mirati & Me
May Provide You With Assistance
- Dosing Information
Search results
Results From The WOW.Com Content Network
A new treatment for locally advanced rectal cancer (LARC) reduced the existence of tumors by twice the amount as previous approaches, eliminating the need for surgery, a new study found.
To create the new standards and address the disparities between treatment in Europe and the U.S., the OSTRiCh (Optimizing Surgical Treatment of Rectal Cancer) Consortium was created by the American College of Surgeons and its Commission on Cancer (CoC) working with the American Society of Colon and Rectal Surgeons (ASCRS), the College of ...
Drug Manufacturer Indication Adagrasib: In combination with cetuximab for the treatment of adults with KRAS G12C mutated locally advanced or metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy [2]
IORT is typically a component in the multidisciplinary treatment of locally advanced and recurrent cancer, in combination with external beam radiation, surgery, and chemotherapy. As a growing trend in recent years, IORT can also be used in earlier stage cancers such as prostate and breast cancer.
Need help? Call us! 800-290-4726 Login / Join. Mail
A new report from the American Cancer Society shows the rise in colorectal cancer among young people, especially men. What to look for, how to screen.
Ads
related to: new rectal cancer treatment breakthrough